Stop losing on size. Start winning on evidence.

Sponsors don’t buy headcount. They buy certainty. Yendou helps mid-cap CROs prove their delivery record, site relationships and strategy with evidence, not scale.

The Evidence

Built by operators from ex-AstraZeneca, Parexel & Microsoft.

Footprint
46.
countries · FDA / EMA / MHRA / PMDA
Reach
23,000+.
research sites · 185+ data points each
EU-built
GDPR.
native by default · EU infrastructure
Yendou products

Three products for the three jobs
between the RFI and the award.

Answer the RFI. Build the country and site strategy. Validate it with sites. Each product runs on your CRO’s own record, and each one leaves the next better informed.

01 · Yendou RFI Qualify more opportunities. Turn previous answers, company knowledge, operational evidence, and SME expertise into stronger sponsor responses without adding work to the proposal team.

Meridian_Torsana_RFI_Response

Torsana · Gastroenterology · Phase 1 · due Aug 20

Reading your RFI... 12 questions 4 drafted 5 have gaps 3 need you Phase 1 gastroenterology studies delivered in the last five years Clinical OperationsDraft ready Phase 1 gastroenterology programmes since 2019, across Belgium and the Netherlands: study count studies, patients screened, median screen failure rate. Drawn from 3 past proposals and your Phase 1 unit SOPs PV Pieter van LoonClinical Operations Outlook Teams Draft attached Export in sponsor format S6_Torsana_RFP_selection_criteria_TOR-501-101.xlsx B12 Missing: study count Type the missing detailFill PV Ask Pieter van LoonSends just this gap, with the drafted answer attached
02 · Yendou Country & Site ID Build a strategy you can defend. Turn protocol requirements, historical performance, and current market intelligence into evidence-backed country and site decisions. Phase 1, gastroenterology Unsaved Drop the protocol synopsis PDF or DOCX Protocol_TOR-501-101_v3.pdf2.4 MB 1. Synopsis 2. Statistical analysis plan Protocol_TOR-501-101_v3.pdfsynopsis & statistical analysis plan Uploading 0% Counting matches... Start from a preset Investigator strength PI publications0.15 PI citations0.25 Delivery evidence Promised against delivered0.30 Zero enrolling site share0.22 Observed recruitment rate0.08 11,221 clinical trials match

4,049 organizations match · showing top 500

Phase 1 gastroenterology · 9 countries · interventional

Reading the delivery ledger... 62 shortlisted 19 under-delivered 7 with no enrolment record Waalstad Medisch Centrum Utrecht, NetherlandsAcademicNo communication on record Comparable trialPromisedDelivered Phase 2 IBD, 20242411Short by 13 Phase 1 GI, 20231814Short by 4 Phase 2 Crohn's, 202230--Not recorded Startup observed 118 days against a 90 day plan · evidence base 3 trials, one incomplete Held back No enrolment recorded against a 30 patient commitment Reserve rank 4 2 selected Add to list Enrol in workflow Clear Choose a workflow CDA signature Blinded feasibility
03 · Yendou Feasibility Validate before you promise. Validate site interest, recruitment, startup, and delivery assumptions with an email-first experience that needs no site login. ← Back Pre-award Feasibility Feasibility survey SECTION 1 / 4 Drop the sponsor feasibility document 0 questions extractedreading the document Section 1 // Engagement and capacity4 sections 43 questions · 4 sectionsready to send Sponsor_Site_Feasibility.docx 1. Engagement and capacity 2. Patient access Step 1: Initial Emailfirst contact with each organization Use template Yendou Library Feasibility (Potential Investigators) [Initial Email]Feasibility questionnaire - {{study_title}} Feasibility (Potential Investigators) [FU1]Following up: feasibility questionnaire FromMara Lindqvist <mara+meridian@yendou.com> Subject Dear Full Name with Title, The purpose of this questionnaire is to assess feasibility for {{study_title}}. • Phase: {{phase}}   • Therapeutic area: {{therapeutic_area}} • Target enrollment: {{patient_number}} patients   • Sites: {{num_sites}} ↗ Click here to complete the questionnaire: Engagement Request link Activate feasibility outreach Reporting Activities 48 Output 32 Dashboard RecipientProgressOrganization Task progress 24 Jul 2026Task started 5:54 PM, a few seconds later1 question prefilled 6:09 PM, 15 minutes laterLast answer updated 17 of 18 required answered Recipient How would you recruit the adult and adolescent patients? Pts Diff. My Pre-award Feasibility view9 charts · 4 KPIs Total submissions32 Total active patient database413 Average CRC workload15.20 Average active database82.60 Reported patient access by site Nordbach150 Silverlund100 Trevaldi58 CRC workload and availability Nordbach25 Silverlund20 Trevaldi12 Priority assigned to this protocol Top 10 priority 40% Top 3 priority 40% Lower priority 20% Primary constraints to performance PI bandwidth2 Patient access1 Drug logistics1 2 selected Export Uplift site responses to Site CRM Clear
Compounding intelligence

Experience should be an unfair advantage.

Every study your CRO pursues and delivers creates intelligence competitors do not have. Yendou captures it, connects it, and puts it to work on every opportunity that follows.

STUDY 01STUDY 01STUDY 01STUDY 03STUDY 02STUDY 01STUDY 03STUDY 02STUDY 01STUDY 03STUDY 02STUDY 06STUDY 05STUDY 04STUDY 03STUDY 02STUDY 06STUDY 05STUDY 04STUDY 03STUDY 02STUDY 06STUDY 05STUDY 04STUDY 08STUDY 07STUDY 06STUDY 05STUDY 04STUDY 08STUDY 07STUDY 06STUDY 05STUDY 04STUDY 08STUDY 07STUDY 09STUDY 08STUDY 07STUDY 09STUDY 08STUDY 07STUDY 09STUDY 09STUDY 09RFI & proposal contentDelivery strategyCountry & site strategyRecruitment benchmarksSite performanceStudy 01Study 02Study 03Study 04Study 05Study 06Study 07Study 08Study 09
The bid window

Winning the study takes more than writing the proposal.

CROs have ten days to build a project delivery strategy and prove it. But gathering data, chasing SMEs, and waiting on sites consume the window. Validation gets whatever time is left. Yendou turns ten days of coordination into ten days of competitive strategy.

RFIThe gate
Qualify the CRO
Search previous answers
Chase SMEs
Reconcile responses
Polish and format
Answered from your record
Only gaps routed to SMEs
Commercially polished
Qualified to bid
Yendou RFI
RFPTen working days
Build a project delivery strategy
01 DevelopCountry & site intelligence
How we believe it should run
02 ValidatePre award feasibility
What the evidence says Whatever can still be checked
03 AssembleProposal
Whatever came backPackage
The window
OUTDay ten
What the sponsor receives

Proposal

  • Project delivery strategy
  • Delivery plan
  • Budget
  • Evidence based validation
  • Project delivery strategy
  • Validated assumptions
  • Validated delivery plan
  • Validated budget
SubmittedReady for bid defence →
Award

The strategy gets written. It rarely gets tested.

Ten days disappear into gathering, chasing, and assembling.

Develop the strategy. Validate it. Then make the proposal.

The same ten days, spent on the argument instead of the chase.

Customer outcomes
“We constantly talk about agility and flexibility as differentiators, but are aware that all of our competitors say those things too. We picked Yendou to be able to show proof more easily. That’s what will be more meaningful to a customer. With Yendou, it’s no longer just words.”
VP Business Development Mid-size CRO · 3,500 FTE · US, EU, APAC
“My team moved from chasing functions for RFI answers and sites for feasibility and signatures to building strategy, producing evidence, and strengthening relationships.”
Chief Commercial Officer Mid-cap CRO · After 90 days with Yendou
“We take in five RFPs per week, and it’s never seamless. In a big company, people have lots of competing demands, so it always becomes a last-minute exercise. It’s just horrible. With Yendou, the timeline alone is saving me about half an hour per RFI, and another half-hour to an hour per department head. It’s better. It’s more efficient.”
Head of Global Proposals and Feasibility Global full-service CRO · US, EU, APAC
The other half of the story

The first platform sites don’t resent.

The site told you once. Yendou remembers forever. No portal, no login, no question they have already answered. Sites reply in days because they are not doing it twice.

“My experience? Well, it was really easy. I was able to click, click, click and see everything. It’s very nice. It’s very clean. It’s got a very nice overview. I really like it.
Annette ZauchaElligo Clinical Research
“You’re offering site networks a level of control and comfort we never experienced before. We’re being notified when there’s opportunities, and not worrying about our sites falling off a list. They won’t be forgotten.
Brayden RandlemanProfound Research
  • 23,000+Research sites
  • 46Countries
  • 185+Data points per site
  • >91%Answer a feasibility in under 5 days
Enterprise ready

Built for the infrastructure you already have.

Yendou works with your existing systems of record and meets the security requirements of regulated clinical research.

Works with your stack
Keep the systems your teams already rely on.
Signature
  • Adobe Sign
  • DocuSign
Systems of record
  • eTMF
  • CTMS
  • Veeva Vault
Workplace
  • Google Workspace
  • Microsoft 365
See integrations
Built for regulated research
Enterprise security and compliance.
Regulatory
  • GDPR
  • 21 CFR Part 11
Controls
  • No AI training
  • Immutable audit logs
  • Role-based access
Compliance
  • ISO 27001
  • SOC 2 Type II
Security documentation

Privacy

Your relationship data is not our training data.

Yendou does not train AI models on customer data. Your feasibility history, delivery evidence and site relationships remain yours.

API. MCP.Bring Yendou into your AI tools.

Connect Claude, ChatGPT or your internal systems to Yendou. Launch feasibility, read responses, update selections and move approved decisions into the study workflow, without copying information between tools.

Your next bid

Make the next study you bid for
the one you win.

See how Yendou turns your CRO’s existing knowledge, expert capacity, and delivery experience into a stronger competitive strategy.

Book an RFP walkthrough